 | • レポートコード：MRC-IM30029 • 出版社/出版日：IMARC / 2022年10月 • レポート形態：英文、PDF、147ページ • 納品方法：Eメール • 産業分類：医療 |
| Single User | ￥374,850 (USD2,499) | ▷ お問い合わせ |
| Enterprisewide | ￥674,850 (USD4,499) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| グローバル調査会社のIMARC社は、2021年に218.2百万ドルであった世界の腎デナベーションシステム市場規模が、2022年から2027年の間にCAGR 40.67％で成長し、2027年までに1,723.6百万ドルに達すると予測しています。本調査レポートでは、腎デナベーションシステムの世界市場について総合的に調査・分析し、序論、範囲・調査手法、エグゼクティブサマリー、イントロダクション、製品タイプ別（カテーテル、RFジェネレータ、神経変性剤）分析、製品別（Symplicity、Vessix（V2）、EnligHTN、Paradise、Iberis）分析、技術別（超音波アブレーション、高周波アブレーション、マイクロインフュージョン）分析、用途別（高血圧症、心疾患、糖尿病、腎不全、その他）分析、地域別（北米、アジア、欧州、中南米、中東・アフリカ）分析、SWOT分析（強み・弱み・機会・脅威）、バリューチェーン分析、ファイブフォース分析、価格分析、競争状況などの項目をまとめています。なお、本書に掲載されている企業情報には、Boston Scientific Group, Kona Medical Inc., Medtronic Plc, Mercator MedSystems, ReCor Medical Inc. (Otsuka Holdings Co. Ltd.), Renal Dynamics, St. Jude Medical Inc. (Abbott), Terumo Corporationなどが含まれています。 ・序論 ・範囲・調査手法 ・エグゼクティブサマリー ・イントロダクション ・世界の腎デナベーションシステム市場規模：製品タイプ別 - カテーテルの市場規模 - RFジェネレータの市場規模 - 神経変性剤の市場規模 ・世界の腎デナベーションシステム市場規模：製品別 - Symplicityの市場規模 - Vessix（V2）の市場規模 - EnligHTNの市場規模 - Paradiseの市場規模 - Iberisの市場規模 ・世界の腎デナベーションシステム市場規模：技術別 - 超音波アブレーションの市場規模 - 高周波アブレーションの市場規模 - マイクロインフュージョンの市場規模 ・世界の腎デナベーションシステム市場規模：用途別 - 高血圧症における市場規模 - 心疾患における市場規模 - 糖尿病における市場規模 - 腎不全における市場規模 - その他用途における市場規模 ・世界の腎デナベーションシステム市場規模：地域別 - 北米の腎デナベーションシステム市場規模 - アジアの腎デナベーションシステム市場規模 - 欧州の腎デナベーションシステム市場規模 - 中南米の腎デナベーションシステム市場規模 - 中東・アフリカの腎デナベーションシステム市場規模 ・SWOT分析（強み・弱み・機会・脅威） ・バリューチェーン分析 ・ファイブフォース分析 ・価格分析 ・競争状況 |
The global renal denervation systems market size reached US$ 218.2 Million in 2021. Looking forward, IMARC Group expects the market to reach US$ 1,723.6 Million by 2027, exhibiting a growth rate (CAGR) of 40.67% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
Renal denervation (RDN) is an interventional procedure that involves a catheter-based ablation of the sympathetic nerves within the renal artery wall. It maximizes nerve disruption, lowers renin secretion, stimulates natriuresis, and improves renal hemodynamics or blood flow. As a result, RDN systems are extensively used to treat refractory hypertension cases wherein optimal therapy cannot provide relief to the patients.
A significant rise in the prevalence of lifestyle diseases, such as hypertension, on account of the increasing number of individuals who smoke and consume alcohol, rising unhealthy dietary patterns, sedentary and hectic lifestyles, and the growing geriatric population represents, one of the key factors strengthening market growth. Apart from this, the advantages associated with the RDN system, such as fast recovery, safety, time efficiency and cost-effectiveness, are acting as another major growth-inducing factor. Furthermore, the escalating demand for minimally invasive (MI) surgery is also contributing to the growth of the market. The introduction of micro-infusion technology, improving healthcare infrastructure, increasing research and development (R&D) activities and the rising number of filings for regulatory approvals of the systems, are also creating a positive influence on the market growth. Although, a decline in the hospital visits and rescheduling of elective health procedures due to the surging cases of the coronavirus disease (COVID-19) have impacted the market growth.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global renal denervation systems market report, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on product type, product, technology, application and end user.
Breakup by Product Type:
Catheters
Single Electrode Catheter
Multi Electrode Catheter
RF Generator
Nerve Modifying Agents
Breakup by Product:
Symplicity
Vessix (V2)
EnligHTN
Paradise
Iberis
Others
Breakup by Technology:
Ultrasound Ablation
Radiofrequency Ablation
Microinfusion
Breakup by Application:
Hypertension
Cardiac Disorders
Diabetes
Renal Failure
Others
Breakup by End User:
Diagnostic Centers and Hospitals
Ambulatory Care Centers
Others
Breakup by Region:
North America
United States
Canada
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The report has also analysed the competitive landscape of the market with some of the key players being Boston Scientific Group, Kona Medical Inc., Medtronic Plc, Mercator MedSystems, ReCor Medical Inc. (Otsuka Holdings Co. Ltd.), Renal Dynamics, St. Jude Medical Inc. (Abbott) and Terumo Corporation.
Key Questions Answered in This Report:
How has the global renal denervation systems market performed so far and how will it perform in the coming years?
What are the key regional markets?
What has been the impact of COVID-19 on the global renal denervation systems market?
What is the breakup of the market based on the product type?
What is the breakup of the market based on the product?
What is the breakup of the market based on the technology?
What is the breakup of the market based on the application?
What is the breakup of the market based on the end user?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global renal denervation systems market and who are the key players?
What is the degree of competition in the industry?
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Renal Denervation Systems Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Product Type
6.1 Catheters
6.1.1 Market Trends
6.1.2 Major Types
6.1.2.1 Single Electrode Catheter
6.1.2.2 Multi Electrode Catheter
6.1.3 Market Forecast
6.2 RF Generator
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Nerve Modifying Agents
6.3.1 Market Trends
6.3.2 Market Forecast
7 Market Breakup by Product
7.1 Symplicity
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Vessix (V2)
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 EnligHTN
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Paradise
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Iberis
7.5.1 Market Trends
7.5.2 Market Forecast
7.6 Others
7.6.1 Market Trends
7.6.2 Market Forecast
8 Market Breakup by Technology
8.1 Ultrasound Ablation
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Radiofrequency Ablation
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Microinfusion
8.3.1 Market Trends
8.3.2 Market Forecast
9 Market Breakup by Application
9.1 Hypertension
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Cardiac Disorders
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Diabetes
9.3.1 Market Trends
9.3.2 Market Forecast
9.4 Renal Failure
9.4.1 Market Trends
9.4.2 Market Forecast
9.5 Others
9.5.1 Market Trends
9.5.2 Market Forecast
10 Market Breakup by End User
10.1 Diagnostic Centers and Hospitals
10.1.1 Market Trends
10.1.2 Market Forecast
10.2 Ambulatory Care Centers
10.2.1 Market Trends
10.2.2 Market Forecast
10.3 Others
10.3.1 Market Trends
10.3.2 Market Forecast
11 Market Breakup by Region
11.1 North America
11.1.1 United States
11.1.1.1 Market Trends
11.1.1.2 Market Forecast
11.1.2 Canada
11.1.2.1 Market Trends
11.1.2.2 Market Forecast
11.2 Asia Pacific
11.2.1 China
11.2.1.1 Market Trends
11.2.1.2 Market Forecast
11.2.2 Japan
11.2.2.1 Market Trends
11.2.2.2 Market Forecast
11.2.3 India
11.2.3.1 Market Trends
11.2.3.2 Market Forecast
11.2.4 South Korea
11.2.4.1 Market Trends
11.2.4.2 Market Forecast
11.2.5 Australia
11.2.5.1 Market Trends
11.2.5.2 Market Forecast
11.2.6 Indonesia
11.2.6.1 Market Trends
11.2.6.2 Market Forecast
11.2.7 Others
11.2.7.1 Market Trends
11.2.7.2 Market Forecast
11.3 Europe
11.3.1 Germany
11.3.1.1 Market Trends
11.3.1.2 Market Forecast
11.3.2 France
11.3.2.1 Market Trends
11.3.2.2 Market Forecast
11.3.3 United Kingdom
11.3.3.1 Market Trends
11.3.3.2 Market Forecast
11.3.4 Italy
11.3.4.1 Market Trends
11.3.4.2 Market Forecast
11.3.5 Spain
11.3.5.1 Market Trends
11.3.5.2 Market Forecast
11.3.6 Russia
11.3.6.1 Market Trends
11.3.6.2 Market Forecast
11.3.7 Others
11.3.7.1 Market Trends
11.3.7.2 Market Forecast
11.4 Latin America
11.4.1 Brazil
11.4.1.1 Market Trends
11.4.1.2 Market Forecast
11.4.2 Mexico
11.4.2.1 Market Trends
11.4.2.2 Market Forecast
11.4.3 Others
11.4.3.1 Market Trends
11.4.3.2 Market Forecast
11.5 Middle East and Africa
11.5.1 Market Trends
11.5.2 Market Breakup by Country
11.5.3 Market Forecast
12 SWOT Analysis
12.1 Overview
12.2 Strengths
12.3 Weaknesses
12.4 Opportunities
12.5 Threats
13 Value Chain Analysis
14 Porters Five Forces Analysis
14.1 Overview
14.2 Bargaining Power of Buyers
14.3 Bargaining Power of Suppliers
14.4 Degree of Competition
14.5 Threat of New Entrants
14.6 Threat of Substitutes
15 Price Analysis
16 Competitive Landscape
16.1 Market Structure
16.2 Key Players
16.3 Profiles of Key Players
16.3.1 Boston Scientific Group
16.3.1.1 Company Overview
16.3.1.2 Product Portfolio
16.3.1.3 Financials
16.3.1.4 SWOT Analysis
16.3.2 Kona Medical Inc.
16.3.2.1 Company Overview
16.3.2.2 Product Portfolio
16.3.3 Medtronic Plc
16.3.3.1 Company Overview
16.3.3.2 Product Portfolio
16.3.3.3 Financials
16.3.3.4 SWOT Analysis
16.3.4 Mercator MedSystems
16.3.4.1 Company Overview
16.3.4.2 Product Portfolio
16.3.5 ReCor Medical Inc. (Otsuka Holdings Co. Ltd.)
16.3.5.1 Company Overview
16.3.5.2 Product Portfolio
16.3.6 Renal Dynamics
16.3.6.1 Company Overview
16.3.6.2 Product Portfolio
16.3.7 St. Jude Medical Inc. (Abbott)
16.3.7.1 Company Overview
16.3.7.2 Product Portfolio
16.3.8 Terumo Corporation
16.3.8.1 Company Overview
16.3.8.2 Product Portfolio
16.3.8.3 Financials
16.3.8.4 SWOT Analysis
Figure 2: Global: Renal Denervation Systems Market: Sales Value (in Million US$), 2016-2021
Figure 3: Global: Renal Denervation Systems Market: Breakup by Product Type (in %), 2021
Figure 4: Global: Renal Denervation Systems Market: Breakup by Product (in %), 2021
Figure 5: Global: Renal Denervation Systems Market: Breakup by Technology (in %), 2021
Figure 6: Global: Renal Denervation Systems Market: Breakup by Application (in %), 2021
Figure 7: Global: Renal Denervation Systems Market: Breakup by End User (in %), 2021
Figure 8: Global: Renal Denervation Systems Market: Breakup by Region (in %), 2021
Figure 9: Global: Renal Denervation Systems Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 10: Global: Renal Denervation Systems (Catheters) Market: Sales Value (in Million US$), 2016 & 2021
Figure 11: Global: Renal Denervation Systems (Catheters) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 12: Global: Renal Denervation Systems (RF Generator) Market: Sales Value (in Million US$), 2016 & 2021
Figure 13: Global: Renal Denervation Systems (RF Generator) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 14: Global: Renal Denervation Systems (Nerve Modifying Agents) Market: Sales Value (in Million US$), 2016 & 2021
Figure 15: Global: Renal Denervation Systems (Nerve Modifying Agents) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 16: Global: Renal Denervation Systems (Symplicity) Market: Sales Value (in Million US$), 2016 & 2021
Figure 17: Global: Renal Denervation Systems (Symplicity) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 18: Global: Renal Denervation Systems (Vessix- V2) Market: Sales Value (in Million US$), 2016 & 2021
Figure 19: Global: Renal Denervation Systems (Vessix- V2) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 20: Global: Renal Denervation Systems (EnligHTN) Market: Sales Value (in Million US$), 2016 & 2021
Figure 21: Global: Renal Denervation Systems (EnligHTN) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 22: Global: Renal Denervation Systems (Paradise) Market: Sales Value (in Million US$), 2016 & 2021
Figure 23: Global: Renal Denervation Systems (Paradise) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 24: Global: Renal Denervation Systems (Iberis) Market: Sales Value (in Million US$), 2016 & 2021
Figure 25: Global: Renal Denervation Systems (Iberis) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 26: Global: Renal Denervation Systems (Other Product Types) Market: Sales Value (in Million US$), 2016 & 2021
Figure 27: Global: Renal Denervation Systems (Other Product Types) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 28: Global: Renal Denervation Systems (Ultrasound Ablation) Market: Sales Value (in Million US$), 2016 & 2021
Figure 29: Global: Renal Denervation Systems (Ultrasound Ablation) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 30: Global: Renal Denervation Systems (Radiofrequency Ablation) Market: Sales Value (in Million US$), 2016 & 2021
Figure 31: Global: Renal Denervation Systems (Radiofrequency Ablation) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 32: Global: Renal Denervation Systems (Microinfusion) Market: Sales Value (in Million US$), 2016 & 2021
Figure 33: Global: Renal Denervation Systems (Microinfusion) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 34: Global: Renal Denervation Systems (Hypertension) Market: Sales Value (in Million US$), 2016 & 2021
Figure 35: Global: Renal Denervation Systems (Hypertension) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 36: Global: Renal Denervation Systems (Cardiac Disorders) Market: Sales Value (in Million US$), 2016 & 2021
Figure 37: Global: Renal Denervation Systems (Cardiac Disorders) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 38: Global: Renal Denervation Systems (Diabetes) Market: Sales Value (in Million US$), 2016 & 2021
Figure 39: Global: Renal Denervation Systems (Diabetes) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 40: Global: Renal Denervation Systems (Renal Failure) Market: Sales Value (in Million US$), 2016 & 2021
Figure 41: Global: Renal Denervation Systems (Renal Failure) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 42: Global: Renal Denervation Systems (Other Applications) Market: Sales Value (in Million US$), 2016 & 2021
Figure 43: Global: Renal Denervation Systems (Other Applications) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 44: Global: Renal Denervation Systems (Diagnostic Centers and Hospitals) Market: Sales Value (in Million US$), 2016 & 2021
Figure 45: Global: Renal Denervation Systems (Diagnostic Centers and Hospitals) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 46: Global: Renal Denervation Systems (Ambulatory Care Centers) Market: Sales Value (in Million US$), 2016 & 2021
Figure 47: Global: Renal Denervation Systems (Ambulatory Care Centers) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 48: Global: Renal Denervation Systems (Other End Users) Market: Sales Value (in Million US$), 2016 & 2021
Figure 49: Global: Renal Denervation Systems (Other End Users) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 50: North America: Renal Denervation Systems Market: Sales Value (in Million US$), 2016 & 2021
Figure 51: North America: Renal Denervation Systems Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 52: United States: Renal Denervation Systems Market: Sales Value (in Million US$), 2016 & 2021
Figure 53: United States: Renal Denervation Systems Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 54: Canada: Renal Denervation Systems Market: Sales Value (in Million US$), 2016 & 2021
Figure 55: Canada: Renal Denervation Systems Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 56: Asia Pacific: Renal Denervation Systems Market: Sales Value (in Million US$), 2016 & 2021
Figure 57: Asia Pacific: Renal Denervation Systems Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 58: China: Renal Denervation Systems Market: Sales Value (in Million US$), 2016 & 2021
Figure 59: China: Renal Denervation Systems Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 60: Japan: Renal Denervation Systems Market: Sales Value (in Million US$), 2016 & 2021
Figure 61: Japan: Renal Denervation Systems Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 62: India: Renal Denervation Systems Market: Sales Value (in Million US$), 2016 & 2021
Figure 63: India: Renal Denervation Systems Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 64: South Korea: Renal Denervation Systems Market: Sales Value (in Million US$), 2016 & 2021
Figure 65: South Korea: Renal Denervation Systems Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 66: Australia: Renal Denervation Systems Market: Sales Value (in Million US$), 2016 & 2021
Figure 67: Australia: Renal Denervation Systems Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 68: Indonesia: Renal Denervation Systems Market: Sales Value (in Million US$), 2016 & 2021
Figure 69: Indonesia: Renal Denervation Systems Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 70: Others: Renal Denervation Systems Market: Sales Value (in Million US$), 2016 & 2021
Figure 71: Others: Renal Denervation Systems Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 72: Europe: Renal Denervation Systems Market: Sales Value (in Million US$), 2016 & 2021
Figure 73: Europe: Renal Denervation Systems Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 74: Germany: Renal Denervation Systems Market: Sales Value (in Million US$), 2016 & 2021
Figure 75: Germany: Renal Denervation Systems Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 76: France: Renal Denervation Systems Market: Sales Value (in Million US$), 2016 & 2021
Figure 77: France: Renal Denervation Systems Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 78: United Kingdom: Renal Denervation Systems Market: Sales Value (in Million US$), 2016 & 2021
Figure 79: United Kingdom: Renal Denervation Systems Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 80: Italy: Renal Denervation Systems Market: Sales Value (in Million US$), 2016 & 2021
Figure 81: Italy: Renal Denervation Systems Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 82: Spain: Renal Denervation Systems Market: Sales Value (in Million US$), 2016 & 2021
Figure 83: Spain: Renal Denervation Systems Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 84: Russia: Renal Denervation Systems Market: Sales Value (in Million US$), 2016 & 2021
Figure 85: Russia: Renal Denervation Systems Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 86: Others: Renal Denervation Systems Market: Sales Value (in Million US$), 2016 & 2021
Figure 87: Others: Renal Denervation Systems Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 88: Latin America: Renal Denervation Systems Market: Sales Value (in Million US$), 2016 & 2021
Figure 89: Latin America: Renal Denervation Systems Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 90: Brazil: Renal Denervation Systems Market: Sales Value (in Million US$), 2016 & 2021
Figure 91: Brazil: Renal Denervation Systems Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 92: Mexico: Renal Denervation Systems Market: Sales Value (in Million US$), 2016 & 2021
Figure 93: Mexico: Renal Denervation Systems Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 94: Others: Renal Denervation Systems Market: Sales Value (in Million US$), 2016 & 2021
Figure 95: Others: Renal Denervation Systems Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 96: Middle East and Africa: Renal Denervation Systems Market: Sales Value (in Million US$), 2016 & 2021
Figure 97: Middle East and Africa: Renal Denervation Systems Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 98: Global: Renal Denervation Systems Industry: SWOT Analysis
Figure 99: Global: Renal Denervation Systems Industry: Value Chain Analysis
Figure 100: Global: Renal Denervation Systems Industry: Porter’s Five Forces Analysis